AI
Wednesday, December 22, 2021 11:53:54 AM
Gut Microbiome and Blarcamesine - Further Evidence of Wide Therapeutic Market
The following slides are a small taste of a refined company overview being prepared. Version 1.2 will include additional MOA functions such as REM sleep, chromatin remodeling/gene expression, autophagic homeostasis, neuro-inflammation reduction, dopamine activation, serotonin activation, endothelial regulation, GABA reduction, seizure protection, ATP production, calcium regulation, increased BDNF, neurogenesis, and XBP1 translation.
Once complete, investors can instantaneously find intriguing connections between Blarcamesine's MOA, therapeutic effects, and numerous diseases/ailments. I hope to have the rest of the slides out within the next 7-10 days.
The following slides are a small taste of a refined company overview being prepared. Version 1.2 will include additional MOA functions such as REM sleep, chromatin remodeling/gene expression, autophagic homeostasis, neuro-inflammation reduction, dopamine activation, serotonin activation, endothelial regulation, GABA reduction, seizure protection, ATP production, calcium regulation, increased BDNF, neurogenesis, and XBP1 translation.
Once complete, investors can instantaneously find intriguing connections between Blarcamesine's MOA, therapeutic effects, and numerous diseases/ailments. I hope to have the rest of the slides out within the next 7-10 days.
